2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
There's nothing wrong with owning index funds, but growth stocks by definition outpace the revenue or profit of a typical stock, which likely results in greater gains than index funds can produce.
Vertex Pharmaceuticals (NASDAQ: VRTX) and Novo Nordisk (NYSE: NVO) fit the definition of a growth stock. These two pharmaceutical companies have products that have helped them outpace the S 500's total return over the past five years, and they certainly have the potential to continue doing so.
Vertex, known for its range of cystic fibrosis (CF) therapies, has increased revenue by 193% over the past five years -- and the company's growth trend could just be getting started.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
428,05 €
0,26 %
Mit 57 Buy-Einschätzungen und nur 2 Sell-Einschätzungen ist Vertex Pharmaceuticals Inc. einer der Lieblinge unserere Community.
Die Community prognostiziert für Vertex Pharmaceuticals Inc. ein Kursziel von 440 €, was einen leichten Anstieg gegenüber 428.05 € darstellt.
